Twenty-one percent of HBeAg-negative patients with persistently normal ALT (PNALT) and HBV DNA <2 × 104 IU/ml had histologically active liver disease [histological activity index (HAI) ≥3 and/or fibrosis stage ≥2]. This evidence concerns the gene GPT and liver disorder.